The biopharmaceutical industry has experienced incredible exponential growth in recent decades. Annual revenues have increased from US$4.4 billion (£3.4 billion) in 1990 to $275 billion (£213 billion) in 2018 (a… Read More »
Read MoreCrystal Lake, Illinois and Orlando, Florida (October 5, 2020) — Noble and Aptar Pharma are pleased to announce the launch of AdhereIT® — a connected, intuitive and user-friendly onboarding solution… Read More »
Read MoreEnvironmental sustainability is a broad, expansive concept that can apply to everything from agriculture and manufacturing to building design. But how is it defined? The US Environmental Protection Agency (EPA)… Read More »
Read MoreAdhereIT 360 Base Demonstration Video:
Read MoreThe Internet of Things (IoT) and connected devices have transformed our everyday lives, from web-connected televisions and smart kitchen appliances to fitness trackers and home security systems. Similarly, connected medical… Read More »
Read MoreTim McLeroy is an industry pioneer with a groundbreaking career in product development and marketing for global pharmaceutical brands ORLANDO, Fla. (June 24, 2020) – Noble, an Aptar Pharma company,… Read More »
Read MoreNemera, world leader in design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generic industries, today announced a collaboration with Noble, the global leader in medical… Read More »
Read MoreWith more biologics and drug delivery device options entering the market in recent years, pharma companies can decide whether it would be easier for patients to self-inject with an autoinjector… Read More »
Read MoreNoble Names Aptar Executive to Director of Account Management Newly-created position will focus on representing the customers’ interests and maximizing Noble’s value by bringing solutions to customer challenges ORLANDO, Fla…. Read More »
Read MoreORLANDO, Fla. (April 30, 2020) – Telemedicine is poised to become a mainstream alternative to the traditional in-person methods of care delivery, with the COVID-19 pandemic easing barriers to acceptance… Read More »
Read More